Anika Therapeutics, Inc.

JPMORGAN CHASE & CO ANIK

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/11/2026

Shares

33,334

Value ($000)

320

Weight

0.0%

2013 Q4 - 2025 Q4 (26 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/11/2026	320	0.0%	33,334	12/31/2025
2025 Q3	11/7/2025	253	0.0%	26,863	9/30/2025
2025 Q2	8/12/2025	284	0.0%	26,811	6/30/2025
2025 Q1	5/12/2025	558	0.0%	37,145	3/31/2025
2024 Q4	2/12/2025	1,358	0.0%	82,491	12/31/2024
2024 Q3	11/8/2024	383	0.0%	15,509	9/30/2024
2024 Q2	8/12/2024	673	0.0%	26,581	6/30/2024
2024 Q1	5/10/2024	695	0.0%	27,375	3/31/2024
2023 Q4	2/12/2024	688	0.0%	30,349	12/31/2023
2023 Q3	11/14/2023	267	0.0%	14,332	9/30/2023
2023 Q2	8/11/2023	470	0.0%	18,072	6/30/2023
2023 Q1	5/18/2023	428	0.0%	14,936	3/31/2023
2022 Q4	2/13/2023	334	0.0%	11,264	12/31/2022
2022 Q3	11/14/2022	253	0.0%	10,606	9/30/2022
2022 Q2	8/11/2022	218	0.0%	9,750	6/30/2022
2022 Q1	5/11/2022	215	0.0%	8,552	3/31/2022
2021 Q4	2/11/2022	350	0.0%	9,778	12/31/2021
2021 Q3	11/12/2021	282	0.0%	6,636	9/30/2021
2021 Q2	8/12/2021	289	0.0%	6,666	6/30/2021
2021 Q1	5/12/2021	259	0.0%	6,327	3/31/2021
2020 Q4	2/19/2021	405	0.0%	8,955	12/31/2020
2020 Q3	11/12/2020	272	0.0%	7,943	9/30/2020
2020 Q2	8/11/2020	277	0.0%	7,347	6/30/2020
2020 Q1	5/12/2020	207	0.0%	7,194	3/31/2020
2019 Q4	2/11/2020	380	0.0%	7,347	12/31/2019
2013 Q4	2/26/2014	566	0.0%	14,840	12/31/2013